Episode

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor

Podcast: Lung Cancer Update
Published: Apr 10, 2025
Duration seconds: 3448
Processing state: not_requested
Canonical source: https://lung-cancer-update.captivate.fm/episode/5293-firstlinetherapyalkmnsclc24
Audio: https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/6aaf6f8a-150e-4400-9c10-9c57425999c7/FirstLineTherapyALKmNSCLC24-converted.mp3
JSON: /v1/public/podcasts/lung-cancer-update-827388/episodes/first-line-therapy-for-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement-an-interview-with-dr-justin-f-gainor
Markdown: /podcast/lung-cancer-update-827388/first-line-therapy-for-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement-an-interview-with-dr-justin-f-gainor.md

Actions

POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/first-line-therapy-for-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement-an-interview-with-dr-justin-f-gainor/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/lung-cancer-update-827388/first-line-therapy-for-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement-an-interview-with-dr-justin-f-gainor.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.  CME information and select publications here .